Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Grigg

Showing results (71-80 of 132) with videos related to

Pageof 14
Sort By:
Internal Medicine Journal|June 17, 2024
Clinical outcomes of chronic myeloid leukaemia patients taking asciminib through a Managed Access Programme (MAP) in AustraliaLynette Chee, Nora Lee, Andrew Grigg, et al.
British Journal of Haematology|October 2, 2014
The oral iron chelator deferasirox inhibits NF-κB mediated gene expression without impacting on proximal activation: implications for myelodysplasia and aplastic anaemiaAshish Banerjee, Nicole A Mifsud, Robert Bird, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 2, 2006
Allogeneic stem cell transplantation with peripheral blood stem cells mobilized by pegylated G-CSFGeoffrey R Hill, Edward S Morris, Madonna Fuery, et al.
The Journal of Antimicrobial Chemotherapy|March 15, 2013
Pharmacoeconomic evaluation of fluconazole, posaconazole and voriconazole for antifungal prophylaxis in patients with acute myeloid leukaemia undergoing first consolidation chemotherapySiow-Chin Heng, Monica A Slavin, Daoud Al-Badriyeh, et al.
Blood|March 8, 2003
Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosisSusan Branford, Zbigniew Rudzki, Sonya Walsh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 31, 2011
Progressive improvement in cutaneous and extracutaneous chronic graft-versus-host disease after a 24-week course of extracorporeal photopheresis--results of a crossover randomized studyHildegard T Greinix, Koen van Besien, Ahmet H Elmaagacli, et al.
European Journal of Haematology|August 19, 2016
Cardiac iron load and function in transfused patients treated with deferasirox (the MILE study)P Joy Ho, Lay Tay, Juliana Teo, et al.
Journal of Environmental Management|February 22, 2022
Next generation restoration metrics: Using soil eDNA bacterial community data to measure trajectories towards rehabilitation targetsCraig Liddicoat, Siegfried L Krauss, Andrew Bissett, et al.
Blood|May 3, 2002
Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantationCharles G Mullighan, Sue Heatley, Kathleen Doherty, et al.
Leukemia & Lymphoma|February 26, 2008
A >or=1 log rise in RQ-PCR transcript levels defines molecular relapse in core binding factor acute myeloid leukemia and predicts subsequent morphologic relapseSteven Lane, Russell Saal, Peter Mollee, et al.
Pageof 14

Showing results (71-80 of 132) with videos related to

Sort By:
Pageof 14
Internal Medicine Journal|June 17, 2024
Clinical outcomes of chronic myeloid leukaemia patients taking asciminib through a Managed Access Programme (MAP) in AustraliaLynette Chee, Nora Lee, Andrew Grigg, et al.
British Journal of Haematology|October 2, 2014
The oral iron chelator deferasirox inhibits NF-κB mediated gene expression without impacting on proximal activation: implications for myelodysplasia and aplastic anaemiaAshish Banerjee, Nicole A Mifsud, Robert Bird, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 2, 2006
Allogeneic stem cell transplantation with peripheral blood stem cells mobilized by pegylated G-CSFGeoffrey R Hill, Edward S Morris, Madonna Fuery, et al.
The Journal of Antimicrobial Chemotherapy|March 15, 2013
Pharmacoeconomic evaluation of fluconazole, posaconazole and voriconazole for antifungal prophylaxis in patients with acute myeloid leukaemia undergoing first consolidation chemotherapySiow-Chin Heng, Monica A Slavin, Daoud Al-Badriyeh, et al.
Blood|March 8, 2003
Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosisSusan Branford, Zbigniew Rudzki, Sonya Walsh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 31, 2011
Progressive improvement in cutaneous and extracutaneous chronic graft-versus-host disease after a 24-week course of extracorporeal photopheresis--results of a crossover randomized studyHildegard T Greinix, Koen van Besien, Ahmet H Elmaagacli, et al.
European Journal of Haematology|August 19, 2016
Cardiac iron load and function in transfused patients treated with deferasirox (the MILE study)P Joy Ho, Lay Tay, Juliana Teo, et al.
Journal of Environmental Management|February 22, 2022
Next generation restoration metrics: Using soil eDNA bacterial community data to measure trajectories towards rehabilitation targetsCraig Liddicoat, Siegfried L Krauss, Andrew Bissett, et al.
Blood|May 3, 2002
Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantationCharles G Mullighan, Sue Heatley, Kathleen Doherty, et al.
Leukemia & Lymphoma|February 26, 2008
A >or=1 log rise in RQ-PCR transcript levels defines molecular relapse in core binding factor acute myeloid leukemia and predicts subsequent morphologic relapseSteven Lane, Russell Saal, Peter Mollee, et al.
Pageof 14